X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Abbott India Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Abbott India Quarterly Results   (KNOL)

Here are the latest quarterly results of Abbott India. For more details, see the Abbott India financial fact sheet and Abbott India share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Abbott India Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-16
3
Sep-16
3
Dec-16
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
8-Qtr Chart
Click to enlarge
Net Sales Rs m7,3817,2947,5577,1547,1479,3108,8157,884 
Other income Rs m139144139155159151190586 
Turnover Rs m7,5217,4387,6967,3097,3069,4609,0058,470 
Expenses Rs m6,3276,2346,3276,5266,5317,2967,1826,817 
Gross profit Rs m1,0541,0601,2316296162,0131,6331,066 
Depreciation Rs m4241443840404240 
Interest Rs m0002056522 
Profit before tax Rs m1,1521,1631,3267257312,1181,7761,591 
Tax Rs m412412470304248743622590 
Profit after tax Rs m7407508564214831,3751,1541,001 
Gross profit margin %14.314.516.38.88.621.618.513.5 
Effective tax rate %35.735.535.542.034.035.135.037.1 
Net profit margin %10.010.311.35.96.814.813.112.7 
Diluted EPS Rs 34.8 35.3 40.3 19.8 22.7 64.7 54.3 47.1  
Diluted EPS (TTM) Rs 124.7 131.0 138.2 130.2 118.1 147.5 161.5 188.8  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Abbott India 4QFY18 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   INDOCO REMEDIES  FULFORD INDIA  AUROBINDO PHARMA  NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare ABBOTT INDIA With:   INDOCO REMEDIES  FULFORD INDIA  AUROBINDO PHARMA  NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 207 Points Higher; Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade in the green during the closing hours of the trading session and ended the day on a positive note.

Views on news

ABBOTT INDIA Announces Quarterly Results (4QFY18); Net Profit Up 137.9% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 137.9% YoY). Sales on the other hand came in at Rs 8 bn (up 10.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

Should You Buy These Mouthwatering High Dividend Stocks?(Profit Hunter)

Aug 1, 2018

Many stocks are yielding dividends even upwards of 4%-5%. Here are the kinds you should pick, and the ones to avoid.

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

NFO - Axis Equity Hybrid Fund: A Worthy Proposition?(Outside View)

Aug 1, 2018

PersonalFN explains if NFO: Axis Equity Hybrid Fund, would be a worthy proposition currently.

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 14, 2018 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ABBOTT INDIA

ABBOTT INDIA - BIOCON LTD COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS